Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.827 | 0.080 | 11 | 119278182 | missense variant | A/C;G | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.827 | 0.080 | 11 | 119278182 | missense variant | A/C;G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.710 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
1.000 | 0.040 | 11 | 119215919 | intron variant | T/A | snv | 0.58 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 11 | 119204719 | upstream gene variant | G/A | snv | 0.62 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 11 | 119229196 | intron variant | G/C | snv | 6.0E-02 |
|
0.800 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
1.000 | 0.040 | 11 | 119229196 | intron variant | G/C | snv | 6.0E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 11 | 119237017 | intron variant | A/G | snv | 0.59 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
11 | 119206293 | upstream gene variant | C/G;T | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
1.000 | 0.040 | 11 | 119237402 | intron variant | A/G | snv | 0.33 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 11 | 119278525 | missense variant | G/A | snv | 4.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.882 | 0.120 | 11 | 119278211 | missense variant | T/A;C | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.882 | 0.120 | 11 | 119278211 | missense variant | T/A;C | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.882 | 0.120 | 11 | 119278211 | missense variant | T/A;C | snv |
|
0.010 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
0.882 | 0.120 | 11 | 119278211 | missense variant | T/A;C | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.080 | 11 | 119206455 | missense variant | G/A | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 11 | 119278170 | missense variant | A/C;G | snv |
|
0.800 | 0 | |||||||||||||
|
0.925 | 0.040 | 11 | 119278214 | missense variant | A/G | snv |
|
0.800 | 0 | ||||||||||||
|
0.807 | 0.240 | 11 | 119278181 | missense variant | T/A;C | snv | 8.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Cardiovascular Diseases | 0.700 | 0 | ||||||||||
|
0.807 | 0.240 | 11 | 119278181 | missense variant | T/A;C | snv | 8.0E-06 |
|
0.700 | 0 | |||||||||||
|
0.807 | 0.240 | 11 | 119278181 | missense variant | T/A;C | snv | 8.0E-06 |
|
Behavior and Behavior Mechanisms | 0.700 | 0 | ||||||||||
|
0.807 | 0.240 | 11 | 119278181 | missense variant | T/A;C | snv | 8.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases | 0.700 | 0 | ||||||||||
|
0.807 | 0.240 | 11 | 119278181 | missense variant | T/A;C | snv | 8.0E-06 |
|
0.700 | 0 | |||||||||||
|
1.000 | 11 | 119278238 | missense variant | G/T | snv |
|
0.800 | 0 | |||||||||||||
|
0.925 | 0.040 | 11 | 119278541 | missense variant | G/A | snv | 4.0E-06 | 2.1E-05 |
|
0.800 | 0 | ||||||||||
|
1.000 | 11 | 119278220 | missense variant | T/C;G | snv |
|
0.700 | 0 |